| Model Number |
305C223 |
| Medical Device Problem Code |
Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Code |
Calcium Deposits/Calcification (1758)
|
| Date of Event |
01/02/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that 9 years and 7 months post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.Evidence of calcium was seen in the right coronary artery (rca), left ventricular outflow tract (lvot) under the non-coronary cusp (ncc) and protruding calcium seen in the abdominal aorta and left femoral artery (lfa).It was stated that anterior calcium was also seen in the right femoral artery (rfa) and anteromedial calcium in the left femoral artery (lfa).No intervention or adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|